Geocann

Geocann is a private, commercial-stage biotech firm positioned as a global leader in cannabinoid formulation and delivery technology. Its core asset is the patented VESIsorb® drug delivery system, a colloidal droplet technology designed to significantly improve the solubility, absorption, and onset time of cannabinoids like CBD and THC. The company operates primarily as a B2B platform, providing its technology and formulations to major brands in the nutraceutical, wellness, and regulated cannabis industries, as evidenced by partnerships with companies like Nestlé Health Science and Cresco Labs. With over 40 granted and pending patents and a portfolio of 25+ market-ready products, Geocann is capitalizing on the growing demand for enhanced bioavailability in the functional ingredients market.

Proprietary VESIsorb® drug delivery system, a patented lipid-based colloidal droplet technology that enhances the solubility, absorption, and bioavailability of lipophilic cannabinoids and botanicals.

Geocann competes with other drug delivery technology firms and ingredient suppliers in the cannabinoid and nutraceutical space. Its key differentiator is its specific, patented VESIsorb® system with clinical backing and NSF certification, which has allowed it to secure partnerships with major brands, giving it a strong competitive position.